Skip to main content

PharmAla Completes GMP Manufacturing of Drug Substance components for ALA-002 Provides Corporate Update Regarding ALA-002 Asset

TORONTO, July 06, 2026 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), announced the successful completion of GMP (Good Manufacturing Practice) manufacturing of drug substance necessary for the manufacturing of ALA-002. This milestone marks a significant step forward in the program’s development, providing sufficient material to support upcoming clinical activities. With drug substance manufacturing now complete, the Company is prepared to begin GMP manufacturing of the drug product, the formulated finished form that will be used in clinical activities globally. The successful scale-up and execution of the drug substance batch under GMP conditions...

Continue reading

Geert Van Poelvoorde to retire as CEO ArcelorMittal Europe

Appointed Chairman of the Board of ArcelorMittal Europe Steel 6 July 2026, 14:05 CET ArcelorMittal today announces that its CEO of Europe and member of the Group Management Committee, Mr Geert Van Poelvoorde, will retire from his executive position at the end of July. He will take up the position of Chairman of the Board of ArcelorMittal Europe Steel. Mr Van Poelvoorde has made an immense contribution to the company since joining as a project engineer in the hot strip mill in Ghent in 1989. His technical expertise combined with his natural leadership skills saw him rise rapidly through the ranks, moving to Bremen in 1995 where he took up responsibility for operations and engineering. He returned to Ghent as Chief Operating Officer, and shortly afterwards, in 2008, became CEO of ArcelorMittal Ghent. Since then, he has held various CEO positions...

Continue reading

Trident Digital Tech Holdings (Nasdaq: TDTH) Founder & CEO to Convert US$8 Million of Debt into Restricted Class B Equity, Strengthening the Company’s Balance Sheet Ahead of Direct Nasdaq Ordinary-Share Trading

240-for-1 Cayman-only share consolidation, together with Founder Soon Huat Lim’s proposed conversion of US$8 million owed by the Company into restricted Class B equity, positions Trident for the anticipated closing of its U.S.-based Digital Innovations Group (DIG) partnership and commercialization of the IRMA AI Engine ahead of the Company’s July 8 Extraordinary General Meeting in Singapore SINGAPORE, July 06, 2026 (GLOBE NEWSWIRE) — Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) (“Trident” or the “Company”), a Singapore-headquartered digital infrastructure and technology holding company, today announced Founder, Chairman and Chief Executive Officer Soon Huat Lim will convert approximately US$8 million of outstanding founder indebtedness into restricted Class B equity, strengthening the Company’s balance sheet, enhancing shareholders’...

Continue reading

Humanoid Global Announces RideScan’s Advancements in Commercial Validation

Vancouver, BC & Edinburgh, Scotland, July 06, 2026 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to provide the following update regarding RideScan Ltd. (“RideScan”), a portfolio company in which Humanoid Global holds a minority equity interest, and its ongoing efforts toward commercial validation of its robotics safety and reliability technology across multiple industries. RideScan has entered into a non-disclosure agreement with a well-established Japanese technology company. Following commercial proposals issued by RideScan, the parties are in active discussions on the structure...

Continue reading

NIOB Intersects 66 metres of Cumulative Pegmatite at Blanchette

Thickest rare earth element carrying pegmatite interval 33.10 metres Vancouver, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) — North American Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) (“NIOB” or the “Company”) has hit encouraging early indications that Blanchette hosts a meaningful rare earth bearing pegmatite system. The first hole drilled on the property in Québec’s Grenville Province intersected 66 metres in total of pegmatite carrying disseminated rare earth element (REE)-bearing minerals—potentially allanite—and associated magnetite. “These visual results are from the first of eight holes planned for Blanchette,” said Murray Nye, Chief Executive Officer. “We chose our drill targets based on where radon data, high-resolution magnetics, and surface mapping all line up with the newly identified...

Continue reading

DEEP SEA MINERALS CORP. SIGNS MOU WITH IMPOSSIBLE METALS TO EVALUATE AUTONOMOUS ROBOTIC NODULE COLLECTION TECHNOLOGY

Vancouver, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) (“Deep Sea Minerals” or the “Company“), a seabed mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with Impossible Metals Inc. (“Impossible Metals”), a U.S.-based marine technology company developing autonomous underwater robotic systems for the selective collection of polymetallic nodules. The MOU establishes a framework for collaboration between Deep Sea Minerals and Impossible Metals with respect to the potential deployment and evaluation of Impossible Metals’ autonomous, riserless robotic collection technology within Deep Sea Minerals’...

Continue reading

PharmaCorp Closes Previously Announced Eight-Store Acquisition and Provides Acquisition Pipeline Update

Eight pharmacies acquired at an aggregate purchase price of approximately $24.2 million The acquisitions increase PharmaCorp’s store count to 14 locations, more than doubling its operating footprintSASKATOON, Saskatchewan, July 06, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, is pleased to announce that, further to its April 30, 2026 news release, it has completed the acquisition of all of the shares of eight PharmaChoice Canada-bannered pharmacies located in Eastern Canada (the “Acquisitions”) from two arm’s length vendor groups. The Acquisitions significantly expand PharmaCorp’s presence in Eastern Canada and increase the Corporation’s operating footprint to 14 pharmacies across Canada, up from six. Together...

Continue reading

PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace

Strategic consolidation of two precision manufacturing portfolio companies expected to streamline operations, shared resources, and strengthen the companies’ aerospace manufacturing platformNEWPORT BEACH, Calif., July 06, 2026 (GLOBE NEWSWIRE) — PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”) today announced that it has merged AGA Precision Systems LLC (“AGA”) into A&B Aerospace, Inc. (“A&B Aerospace”), with A&B Aerospace expected to be the surviving operating entity. The merger is designed to simplify PMGC’s aerospace precision manufacturing platform by consolidating two related businesses under one corporate structure. Following the merger, AGA will cease to exist as a separate legal entity, while A&B Aerospace will continue operating the AGA name through a fictitious business name, or DBA,...

Continue reading

Banzai Completes Acquisition of ConnectAndSell, Doubling Annual Revenue at 86% Gross Margin

Acquisition Adds Leading AI Sales Acceleration Platform Serving Approximately 250 B2B Organizations Across Financial Services, Healthcare, and Technology Industries SEATTLE, July 06, 2026 (GLOBE NEWSWIRE) — Banzai International, Inc. (Nasdaq: BNZI) (“Banzai” or the “Company”), a leading AI marketing technology company that provides essential marketing and sales solutions, today announced that it has completed its previously announced acquisition of substantially all assets of ConnectAndSell, Inc. (“ConnectAndSell”), an AI sales acceleration platform, effective July 2, 2026. ConnectAndSell serves approximately 250 B2B organizations such as Intuit, RingCentral, Truckstop, and SAP across financial services, healthcare, technology, and other industries. ConnectAndSell’s FY 2025 revenue was $14.7 million, with a gross margin of 86%,...

Continue reading

Aktietilbagekøb i Djurslands Bank – transaktioner i uge 27

Fondsbørsmeddelelse 35/2026 Djurslands Bank offentliggjorde den 1. september 2025 et aktietilbagekøbsprogram på 35 mio. kr., dog med maksimalt 51.800 aktier. Aktietilbagekøbsprogrammet startede den 1. september 2025 og vil være afsluttet senest den 31. august 2026. Aktietilbagekøbsprogrammet sker med henblik på nedsættelse af aktiekapitalen i banken med op til 25 mio. kr., samt etablering af medarbejderaktieordning med op til 10 mio. kr.Programmet gennemføres i overensstemmelse med artikel 5 i EU-Kommissionens forordning nr. 596/2014 af 16. april 2014 og EU-Kommissionens delegerede forordning nr. 2016/1052 af 8. marts 2016, der tilsammen udgør ”Safe Harbour”-reguleringen. Under aktietilbagekøbsprogrammet er gennemført følgende transaktioner:  Antal aktier Gennemsnitlig købskurs (DKK) Transaktions-værdi (DKK)I alt under aktietilbagekøbsprogrammet 38.381 882,82 33.883.34629....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.